170 related articles for article (PubMed ID: 18218578)
1. Estimation of the financial burden to the National Health Insurance for patients with major cancers in Taiwan.
Chu PC; Hwang JS; Wang JD; Chang YY
J Formos Med Assoc; 2008 Jan; 107(1):54-63. PubMed ID: 18218578
[TBL] [Abstract][Full Text] [Related]
2. Lifetime medical expenditure and life expectancy lost attributable to smoking through major smoking related diseases in Taiwan.
Chung CW; Wang JD; Yu CF; Yang MC
Tob Control; 2007 Dec; 16(6):394-9. PubMed ID: 18048616
[TBL] [Abstract][Full Text] [Related]
3. Managing health expenditure inflation under a single-payer system: Taiwan's National Health Insurance.
Yip WC; Lee YC; Tsai SL; Chen B
Soc Sci Med; 2019 Jul; 233():272-280. PubMed ID: 29548564
[TBL] [Abstract][Full Text] [Related]
4. Estimation of benefit of prevention of occupational cancer for comparative risk assessment: methods and examples.
Lee LJ; Chang YY; Liou SH; Wang JD
Occup Environ Med; 2012 Aug; 69(8):582-6. PubMed ID: 22576592
[TBL] [Abstract][Full Text] [Related]
5. Estimation of life expectancy, loss-of-life expectancy, and lifetime healthcare expenditures for schizophrenia in Taiwan.
Lêng CH; Chou MH; Lin SH; Yang YK; Wang JD
Schizophr Res; 2016 Mar; 171(1-3):97-102. PubMed ID: 26811230
[TBL] [Abstract][Full Text] [Related]
6. Cost effectiveness of cancer treatment in Taiwan.
Hung MC; Lai WW; Chen HH; Lee JC; Lin YJ; Hsiao JR; Cheng YM; Shan YS; Su WC; Wang JD
J Formos Med Assoc; 2016 Aug; 115(8):609-18. PubMed ID: 27302557
[TBL] [Abstract][Full Text] [Related]
7. Impact of work-related cancers in Taiwan-Estimation with QALY (quality-adjusted life year) and healthcare costs.
Lee LJ; Lin CK; Hung MC; Wang JD
Prev Med Rep; 2016 Dec; 4():87-93. PubMed ID: 27413666
[TBL] [Abstract][Full Text] [Related]
8. Healthcare utilization patterns and risk adjustment under Taiwan's National Health Insurance system.
Chang RE; Lin W; Hsieh CJ; Chiang TL
J Formos Med Assoc; 2002 Jan; 101(1):52-9. PubMed ID: 11911039
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of diabetes pay-for-performance incentive designs.
Hsieh HM; Tsai SL; Shin SJ; Mau LW; Chiu HC
Med Care; 2015 Feb; 53(2):106-15. PubMed ID: 25397966
[TBL] [Abstract][Full Text] [Related]
10. Variations in the persistence of health expenditures and the implications for the design of capitation payments in Taiwan.
Ku LJ; Chiou MJ; Liu LF
J Health Serv Res Policy; 2015 Jul; 20(3):146-53. PubMed ID: 25829410
[TBL] [Abstract][Full Text] [Related]
11. National health insurance expenditure for adult beneficiaries in Taiwan in their last year of life.
Liu CN; Yang MC
J Formos Med Assoc; 2002 Aug; 101(8):552-9. PubMed ID: 12440085
[TBL] [Abstract][Full Text] [Related]
12. Perceived Impact of Taiwan's National Health Insurance Allocation Strategy: Health Professionals' Perspective.
Owili PO; Muga MA; Yang YT; Hsu YE
Int J Environ Res Public Health; 2019 Feb; 16(3):. PubMed ID: 30764553
[TBL] [Abstract][Full Text] [Related]
13. Use of diagnosis-based risk adjustment models to predict individual health care expenditure under the National Health Insurance system in Taiwan.
Chang RE; Lai CL
J Formos Med Assoc; 2005 Dec; 104(12):883-90. PubMed ID: 16607444
[TBL] [Abstract][Full Text] [Related]
14. The lifetime cost of hepatocellular carcinoma : a claims data analysis from a medical centre in Taiwan.
Lang HC; Wu JC; Yen SH; Lan CF; Wu SL
Appl Health Econ Health Policy; 2008; 6(1):55-65. PubMed ID: 18774870
[TBL] [Abstract][Full Text] [Related]
15. Life Expectancy and Lifetime Health Care Expenditures for Type 1 Diabetes: A Nationwide Longitudinal Cohort of Incident Cases Followed for 14 Years.
Ou HT; Yang CY; Wang JD; Hwang JS; Wu JS
Value Health; 2016 Dec; 19(8):976-984. PubMed ID: 27987648
[TBL] [Abstract][Full Text] [Related]
16. Myocardial perfusion scintigraphy in Taiwan from 2005 to 2009.
Hung MC; Chang PW; Hsieh WA; Hwang JJ
Nucl Med Commun; 2012 Jul; 33(7):733-8. PubMed ID: 22395035
[TBL] [Abstract][Full Text] [Related]
17. Comparison of expected health impacts for major cancers: integration of incidence rate and loss of quality-adjusted life expectancy.
Hung MC; Lai WW; Chen HH; Su WC; Wang JD
Cancer Epidemiol; 2015 Feb; 39(1):126-32. PubMed ID: 25553846
[TBL] [Abstract][Full Text] [Related]
18. Outpatient drug expenditures and prescription policies for diseases with high cost to the National Health Insurance system in Taiwan.
Lang HC; Lai MS; Chen GT
J Formos Med Assoc; 2004 Apr; 103(4):280-5. PubMed ID: 15175823
[TBL] [Abstract][Full Text] [Related]
19. Lifetime risks, loss of life expectancy, and health care expenditures for 19 types of cancer in Taiwan.
Wu TY; Chung CH; Lin CN; Hwang JS; Wang JD
Clin Epidemiol; 2018; 10():581-591. PubMed ID: 29872347
[TBL] [Abstract][Full Text] [Related]
20. The spillover effect of National Health Insurance on household consumption patterns: evidence from a natural experiment in Taiwan.
Sheu JT; Lu JF
Soc Sci Med; 2014 Jun; 111():41-9. PubMed ID: 24747377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
